1. Home
  2. ELAB vs AEON Comparison

ELAB vs AEON Comparison

Compare ELAB & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELAB
  • AEON
  • Stock Information
  • Founded
  • ELAB 2020
  • AEON N/A
  • Country
  • ELAB United States
  • AEON United States
  • Employees
  • ELAB N/A
  • AEON N/A
  • Industry
  • ELAB
  • AEON Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELAB
  • AEON Health Care
  • Exchange
  • ELAB Nasdaq
  • AEON Nasdaq
  • Market Cap
  • ELAB 6.6M
  • AEON 5.7M
  • IPO Year
  • ELAB 2023
  • AEON N/A
  • Fundamental
  • Price
  • ELAB $2.17
  • AEON $0.82
  • Analyst Decision
  • ELAB
  • AEON Strong Buy
  • Analyst Count
  • ELAB 0
  • AEON 1
  • Target Price
  • ELAB N/A
  • AEON $360.00
  • AVG Volume (30 Days)
  • ELAB 77.7K
  • AEON 1.9M
  • Earning Date
  • ELAB 05-14-2025
  • AEON 05-14-2025
  • Dividend Yield
  • ELAB N/A
  • AEON N/A
  • EPS Growth
  • ELAB N/A
  • AEON N/A
  • EPS
  • ELAB N/A
  • AEON 73.23
  • Revenue
  • ELAB N/A
  • AEON N/A
  • Revenue This Year
  • ELAB N/A
  • AEON N/A
  • Revenue Next Year
  • ELAB N/A
  • AEON N/A
  • P/E Ratio
  • ELAB N/A
  • AEON $0.01
  • Revenue Growth
  • ELAB N/A
  • AEON N/A
  • 52 Week Low
  • ELAB $1.95
  • AEON $0.38
  • 52 Week High
  • ELAB $939.96
  • AEON $269.28
  • Technical
  • Relative Strength Index (RSI)
  • ELAB 37.11
  • AEON 67.31
  • Support Level
  • ELAB $2.06
  • AEON $0.53
  • Resistance Level
  • ELAB $2.23
  • AEON $0.85
  • Average True Range (ATR)
  • ELAB 0.18
  • AEON 0.08
  • MACD
  • ELAB 0.05
  • AEON 0.05
  • Stochastic Oscillator
  • ELAB 29.92
  • AEON 92.78

About ELAB Elevai Labs Inc.

PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Share on Social Networks: